Cadila Healthcare declines on reporting 9% fall in Q4 consolidated net profit

16 May 2014 Evaluate

Cadila Healthcare is currently trading at Rs 922.00, down by 18.25 points or 1.94% from its previous closing of Rs 940.25 on the BSE.

The scrip opened at Rs 949.80 and has touched a high and low of Rs 959.75 and Rs 903.00 respectively. So far 15959 shares were traded on the counter.

The BSE group 'A' stock of face value Rs 5 has touched a 52 week high of Rs 1079.00 on 03-Mar-2014 and a 52 week low of Rs 631.00 on 20-Aug-2013.

Last one week high and low of the scrip stood at Rs 1008.00 and Rs 923.20 respectively. The current market cap of the company is Rs 18657.71 crore.

The promoters holding in the company stood at 74.79% while Institutions and Non-Institutions held 13.98% and 11.23% respectively.

Cadila Healthcare has reported 1.84% fall in its net profit of Rs 216.68 crore for the quarter ended March 31, 2014 as compared to Rs 220.74 crore for the same quarter in the previous year. However, total income of the company increased by 11.83% at Rs 1121.89 crore for quarter under review as compared to Rs 1003.24 crore for the quarter ended March 31, 2013.

On consolidated basis, the company has reported 8.74% fall in its net profit / (loss) after taxes, minority interest and share of profit / (loss) of associates at Rs 239.19 crore for the quarter ended March 31, 2014 as compared to Rs 262.11 crore for the same quarter in the previous year. However, total income of the company has increased by 22.30% at Rs 1981.63 crore for quarter under review as compared to Rs 1620.33 crore for the quarter ended March 31, 2013.

For the year ended March 31, 2014, the company has posted a rise of 81.24% in its net profit after taxes at Rs 903.59 crore as compared to Rs 498.55 crore for the same period in the previous year.  Total income of company improved by 21.51% at Rs 4350.70 crore for year under review as compared to Rs 3580.37 crore for the period ended March 31, 2013.

For the year ended March 31, 2014, on the consolidated basis, the company has posted a rise of 22.97% in its net profit after taxes & Minority interest at Rs 803.59 crore as compared to Rs 653.46 crore for the same period in the previous year. Total income of company has increased by 13.76% at Rs 7274.70 crore for year under review as compared to Rs 6394.78 crore in the previous fiscal.

 

Zydus Lifesciences Share Price

931.45 -3.75 (-0.40%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×